The fastest way to get high-quality market and commercial insights for rare diseases
WHY OUR REPORTS
FAST & FRESH INSIGHTS
Published reports available immediately. New reports created or refreshed upon request, delivered in 15 days.
PRIMARY MARKET RESEARCH-DRIVEN
KOL insights complement secondary research.
WRITTEN BY SENIOR TEAM
Experienced team members (10+ years in pharma market research) lead the research.
BROWSE BY THERAPY AREA
ALL REPORTS
Alopecia Areata (AA)
January 2022
Alport Syndrome
June 2022
ANCA-Associated Vasculitis
January 2023
Angelman Syndrome
February 2024
Arrhythmogenic Cardiomyopathy (ACM)
October 2023
Atopic Dermatitis (Dupixent-Refractory)
June 2023
Bullous Pemphigoid
February 2023
Celiac Disease
October 2022
Chronic Inflammatory Demyelinating Polyneuropathy
July 2022
Classical Homocystinuria
March 2023
Cold Agglutinin Disease (CAD)
Delayed Onset Type 1 Diabetes
Diabetic Retinopathy (DR)
June 2021
Eosinophilic Esophagitis
Frontal Fibrosing Alopecia
Generalized Pustular Psoriasis (GPP)
Geographic Atrophy
July 2023
Glycogen Storage Disease (GSD) Type 1a
August 2023
Gout (Chronic Refractory)
Graves’ Disease
Idiopathic Inflammatory Myopathies
Immunoglobulin A (IgA) Nephropathy
Long QT Syndrome (LQTS)
Membranous Nephropathy
April 2023
Myasthenia Gravis
November 2022
Netherton Syndrome
Pancreatic Ductal Adenocarcinoma (PDAC)
Palmoplantar Pustulosis (PPP)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pemphigus Vulgaris
Prion Disease
August 2024
Prurigo Nodularis (PN)
March 2022
Sickle Cell Disease (SCD)
Sorbitol Dehydrogenase Deficiency (SORD Deficiency)
Spinal Cord Injury (SCI)
STXBP1 Encephalopathy
Tardive Dyskinesia (TD)
December 2023
Don’t see your disease of interest? Contact us.
Reach out to our team to learn more about our capabilities and view sample reports.
